Revance Therapeutics Inc (NASDAQ:RVNC)

29.75
Delayed Data
As of 4:00pm ET
 +1.13 / +3.95%
Today’s Change
22.89
Today|||52-Week Range
33.83
+4.98%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Foley Mark J
President & Chief Executive Officer
Sale9/30/2020143,269$25.14$3.6M+18.22%
Foley Mark J
President & Chief Executive Officer
Sale10/13/202066,106$27.62$1.8M+7.60%
Rankin Aubrey
Sale7/26/202155,382$29.72$1.6M+0.10%
Rankin Aubrey
Sale7/28/202134,332$30.00$1.0M-1.16%
Rankin Aubrey
Sale12/30/202033,119$27.82$921.4K+5.24%
Rankin Aubrey
Sale9/28/202033,119$26.18$867.1K+14.35%
Rankin Aubrey
Sale10/29/202033,119$26.15$866.1K+14.26%
Rankin Aubrey
Sale2/01/202133,119$25.95$859.4K+12.66%
Rankin Aubrey
Sale3/04/202133,119$25.43$842.2K+15.60%
Rankin Aubrey
Sale11/30/202033,119$23.85$789.9K+23.12%
Page of 5